Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>In silico</i> based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches.

ADMET & DMPK·2026

Same author

Hydrogel molecularly imprinted polymer-based electrochemical sensor on gold-modified screen-printed carbon electrodes for stable and selective HbA1c detection.

Biosensors & bioelectronics·2026

Same author

Pharmacokinetics and Toxicity Overview of Active Compounds Berberine, Palmatine, and Jatrorrhizine From <i>Fibraurea tinctoria</i> Lour: Drug-Likeness, ADMET Prediction, and In Vivo Extract Toxicity Assessment.

Journal of toxicology·2026

Same author

Synergistic Potential of Trikatu Essential Oil as an Aromatherapy Agent: A Chemical and Mechanistic Review.

Drug design, development and therapy·2025

Same author

Correlation between A3243G and G9053A mtDNA mutations and ATP levels in diabetes mellitus patients using qPCR and electrochemical aptasensors.

ADMET & DMPK·2025

Same author

Ligand-Free Pd-Catalyzed Direct C-H Arylation of Polyfluoroarenes with Aryl Iodides under Ambient Air Conditions.

Chemistry, an Asian journal·2025

Search research articles

Related Experiment Video

Updated: Jul 21, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Berberine and Its Study as an Antidiabetic Compound.

Ayudiah Rizki Utami¹, Iman Permana Maksum¹, Yusi Deawati¹

¹Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia.

|July 29, 2023

Summary

Berberine, a natural compound, shows promise for treating diabetes by lowering blood glucose and improving insulin sensitivity. Further research is needed to fully understand its antidiabetic mechanisms.

Keywords:

AMPK pathway antidiabetic compound diabetes mellitus hyperglycemia

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jul 21, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Area of Science:

Pharmacology
Natural Product Chemistry
Metabolic Disorders

Background:

Diabetes mellitus (DM) is a growing global health concern characterized by hyperglycemia.
Current diabetes treatments have limitations, including toxicity, driving research into natural alternatives.
Berberine, a plant-derived alkaloid, has demonstrated various bioactivities, including potential antidiabetic effects.

Purpose of the Study:

To review the antidiabetic properties and mechanisms of berberine.
To explore berberine's potential as a natural alternative for diabetes management.
To highlight the need for further investigation into berberine's precise mechanisms of action.

Main Methods:

Literature review of studies on berberine and its effects on diabetes.
Analysis of research investigating berberine's bioactivities and molecular pathways.
Synthesis of findings related to berberine's impact on glucose metabolism and insulin resistance.

Main Results:

Berberine effectively reduces blood glucose levels.
It enhances insulin secretion and improves glucose tolerance.
Berberine activates the AMPK pathway, contributing to its antidiabetic effects.
Additional benefits include anti-adipogenic, anti-hyperlipidemic, anti-inflammatory, and antioxidant activities.

Conclusions:

Berberine exhibits significant antidiabetic potential through multiple mechanisms.
Its diverse pharmacological activities make it a promising natural compound for diabetes treatment.
Further research is essential to elucidate the complete mechanistic profile of berberine.